Work

Dissecting the Impact of the Gut Microbiome on Cancer Immunotherapy

Year: 2023

Type: preprint

Source: Research Square

DOI: 10.21203/rs.3.rs-3647386/v1

Authors: Rakesh Jain, Andreas Hadjigeorgiou, Constantinos Harkos, Aditya Mishra, Golnaz Morad, Sarah Johnson, Nadim Ajami, Jennifer Wargo, Lance Munn, Triantafyllos Stylianopoulos

Institutions: The University of Texas MD Anderson Cancer Center, Harvard University, University of Cyprus, Massachusetts General Hospital

Language: English

Topic: Gut microbiota and health

Subfield: Molecular Biology

Field: Biochemistry, Genetics and Molecular Biology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: green

Funders: European Commission, National Institutes of Health, National Cancer Institute, H2020 European Research Council, FP7 Ideas: European Research Council

Awards: (PQ10) Enhancing responses to immune checkpoint blockade in melanoma via modulation of the microbiome, Multiplexed device for rapid coagulopathy testing, G434337789, Reprogramming PDAC tumor microenvironment to improve immunotherapy, Open Accessibility Everywhere: Groundwork, Infrastructure, Standards, Elucidating the role of gut, blood, and tumor microbiota in brain metastasis, Mechanical Biomarkers for Prediction of Cancer Immunotherapy, Dissecting Pediatric Brain Tumor Microenvironment to Improve Treatment, Tephra constraints on rapid climatic events, Reengineering obesity-induced abnormal microenvironment to improve PDAC treatment, Improving treatment of HER2+ breast cancer brain metastasis by targeting lipid metabolism, Targeting physical stress-driven mechanisms to overcome glioblastoma treatment resistance, Reprogramming the Tumor Microenvironment to Improve Immunotherapy of Glioblastoma by Co-Targeting VEGF and Ang2, Vascularized tumor explants for drug testing

OpenAlex ID: W4389167249

Cites: 39

Cited by: 6

Related to: 10